Table 2 Characteristics of patients and controls recruited

n

97

167

280

Age (year) (median, IQR)

61.7 year (54.0–69.5)

50.1 year (43.8–64.9)

47.0 year (44.2–50.6)

% Male

53.6 % (52/97)

41.3 %

40.4 % (113/280)

Asthma (%)

88.7 % (86/97)

100 % (167/167)

0 % (0/280)

Lung function tests (n)

67

165

255

FEV1 % predicted (median, IQR)

64.0 (51.0–78.0)

96.0 (78.4–108.2)

107.5 (99.6–117.2)

FVC % predicted (median, IQR)

96.0 (87.5–106.5)

108.9 (99.0–118.5)

114.7 (105.6–123.6)

FEV1/FVC ratio (median, IQR)

56.0 (47.9–64.0)

72.0 (63.0–79.0)

79.0 (75.0–83.0)

Markers of ABPA

Bronciectasis (%)

67.0 % (65/97)

N/A

N/A

Total serum IgE (kU/L) (median, IQR) (n)

2250 (1100–4425) (96)

N/A

N/A

Aspergillus specific IgE (kUA/L) (median, IQR) (n)

9.7 (3.2–36.0) (62)

N/A

N/A